Comparison of nitrazepam 5 mg with triazolam 0.5 mg in young psychiatric insomniac inpatients. Double-blind single night cross-over study.
Sixty young male patients with insomniac disorders were treated with nitrazepam 5 mg or triazolam 0.5 mg in a double-blind single night cross-over study. The results were favourable for triazolam in all the sleep parameters assessed. The significance of an hypnotic with a short life and its use in clinical practice is discussed.
D000328:Adult; D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D006801:Humans; D008297:Male; D009567:Nitrazepam / Q000008:administration & dosage / Q000627:therapeutic use*; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy*; D014229:Triazolam / Q000008:administration & dosage / Q000627:therapeutic use*
D014151:Anti-Anxiety Agents; D014229:Triazolam; D009567:Nitrazepam